Increased Sxc- mediated glutamate release was observed even before the reduction in EAAT2, and this contributed to the early glutamate toxicity during the disease initiation in the (SOD1)-G93A transgenic rodent model of ALS [46]. Here, SLC1A2 is linked to amyotrophic lateral sclerosis.